Gesellschaft Deutscher Chemiker
Keine Benachrichtigungen
Sie haben noch keine Lesezeichen


Transition metal complexes with tridentate Schiff bases (O^N^O and O^N^N) derived from salicylaldehyde: An analysis of their potential anticancer activity

Von Wiley-VCH zur Verfügung gestellt

Although it is known that the first case of cancer was recorded in ancient Egypt around 1600 BC, it was not until 1917 during the First World War and the development of mustard gas that chemotherapy against cancer became relevant; however, its properties were recognised until 1946 to later be used in patients. In this sense, the use of metallopharmaceuticals in cancer therapy was extensively explored until the 1960s with the discovery of cisplatin and its anticancer activity. From that date to the present, the search for more effective, more selective metallodrugs with fewer side effects has been an area of continuous exploration. Efforts have led to consider a wide variety of metals from the periodic table, mainly from the d -block, as well as a wide variety of organic ligands, preferably with guaranteed biological activity. In this sense, various research groups have found an ideal binder in Schiff bases, since their raw materials are easily accessible, their synthesis conditions are friendly and their denticity can be manipulated. Therefore, in this review, we have explored the anticancer and antitumor activity reported in the literature for coordination complexes of d -block metals coordinated with tridentate Schiff bases (O^N^O and O^N^N) derived from salicylaldehyde. For this work, we have used the main scientific databases CCDC® and Scifinder®.

Zum Volltext

Überprüfung Ihres Anmeldestatus ...

Wenn Sie ein registrierter Benutzer sind, zeigen wir in Kürze den vollständigen Artikel.